Hepatitis B Virus cccDNA: Formation, Regulation and Therapeutic Potential.

[1]  R. Colonno,et al.  Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature‐Mutation in Treated Chronic Hepatitis B Patients , 2020, Hepatology.

[2]  Lei Wei,et al.  Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation , 2020, Nature Microbiology.

[3]  Jianming Hu,et al.  Role of Hepatitis B virus capsid phosphorylation in nucleocapsid disassembly and covalently closed circular DNA formation , 2020, PLoS pathogens.

[4]  Jianming Hu,et al.  Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation , 2020, mBio.

[5]  Xinwen Chen,et al.  HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription. , 2019, Antiviral research.

[6]  D. Glebe,et al.  Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro , 2019, Microorganisms.

[7]  F. Zoulim,et al.  Therapeutic strategies for hepatitis B virus infection: towards a cure , 2019, Nature Reviews Drug Discovery.

[8]  A. Siddiqui,et al.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies , 2019, Journal of Virology.

[9]  Joan M. Block,et al.  A global scientific strategy to cure hepatitis B. , 2019, The lancet. Gastroenterology & hepatology.

[10]  A. Ryo,et al.  Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization , 2019, Proceedings of the National Academy of Sciences.

[11]  Jinhong Chang,et al.  DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA , 2019, PLoS pathogens.

[12]  Zhipeng Yan,et al.  PS-074-A first-in-class orally available HBV cccDNA destabilizer ccc_R08 achieved sustainable HBsAg and HBV DNA suppression in the HBV circle mouse model through elimination of cccDNA-like molecules in the mouse liver , 2019, Journal of Hepatology.

[13]  M. Dandri,et al.  Comparative analysis of the antiviral effects mediated by type I and III interferons in hepatitis B virus infected hepatocytes. , 2019, The Journal of infectious diseases.

[14]  Joanna L. Parish,et al.  A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis , 2019, Life Science Alliance.

[15]  Jinhong Chang,et al.  Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA , 2019, Journal of Virology.

[16]  M. Heikenwalder,et al.  PASylated interferon &agr; efficiently suppresses hepatitis B virus and induces anti‐HBs seroconversion in HBV‐transgenic mice , 2019, Antiviral research.

[17]  Sun Park,et al.  Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner , 2018, Journal of Virology.

[18]  J. McKeating,et al.  Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. , 2018, Journal of hepatology.

[19]  A. Thierry,et al.  Tridimensional infiltration of DNA viruses into the host genome shows preferential contact with active chromatin , 2018, Nature Communications.

[20]  Juan Chen,et al.  AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo , 2018, International journal of medical sciences.

[21]  T. Block,et al.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host‐targeting agents to treat chronic hepatitis B , 2018, Antiviral research.

[22]  Quanxin Long,et al.  SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3‐9 homolog 1 and SET domain containing 1A histone methyltransferases , 2018, Hepatology.

[23]  A. Bertoletti,et al.  Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3. , 2018, Gastroenterology.

[24]  M. Muramatsu,et al.  Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus , 2018, PLoS pathogens.

[25]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[26]  S. Kottilil,et al.  Chronic Hepatitis B Infection: A Review , 2018, JAMA.

[27]  Lei Yue,et al.  Establishment of Cre‐mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays , 2018, Antiviral research.

[28]  S. Baig,et al.  Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins , 2018, Clinical Epigenetics.

[29]  Haitao Guo,et al.  Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B , 2017, Hepatology.

[30]  Jie-Li Hu,et al.  The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation , 2017, PLoS pathogens.

[31]  T. Volz,et al.  Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection. , 2017, Gastroenterology.

[32]  C. Seeger,et al.  Distribution of Hepatitis B Virus Nuclear DNA , 2017, Journal of Virology.

[33]  Q. Ning,et al.  IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection , 2017, Scientific Reports.

[34]  A. Lok,et al.  Hepatitis B cure: From discovery to regulatory approval , 2017, Journal of hepatology.

[35]  S. Kanner,et al.  RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg , 2017, Science Translational Medicine.

[36]  Allyson E. Koyen,et al.  SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination. , 2017, Cell reports.

[37]  Jiangxia Liu,et al.  PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation , 2017, Hepatology.

[38]  M. Yuen,et al.  Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome , 2017, Antiviral research.

[39]  A. Bertoletti,et al.  Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection , 2017, The Journal of clinical investigation.

[40]  Jianming Hu,et al.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection , 2017, Journal of Virology.

[41]  M. Ghany.  Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon. , 2017, Best practice & research. Clinical gastroenterology.

[42]  M. Nassal,et al.  A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation—and Beyond? , 2017, Viruses.

[43]  A. Lohse,et al.  Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo , 2017, Gut.

[44]  S. Urban,et al.  HBV DNA Integration: Molecular Mechanisms and Clinical Implications , 2017, Viruses.

[45]  Chaojie Yang,et al.  Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9 , 2017, Front. Cell. Infect. Microbiol..

[46]  T. Liang,et al.  Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. , 2017, Journal of hepatology.

[47]  C. Delaugerre,et al.  Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. , 2016, Journal of hepatology.

[48]  Wenhui Li,et al.  DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus , 2016, PLoS pathogens.

[49]  Haitao Guo,et al.  Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA. , 2016, Antiviral research.

[50]  Yanbao Yu,et al.  Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication. , 2016, Cell reports.

[51]  H. Zhang,et al.  RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis , 2016, Hepatology.

[52]  C. Cinti,et al.  Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective. , 2016, Current pharmaceutical biotechnology.

[53]  C. Seeger,et al.  Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  S. Fletcher,et al.  Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor , 2016, Nature.

[55]  B. Slagle,et al.  Hepatitis B Virus X and Regulation of Viral Gene Expression. , 2016, Cold Spring Harbor perspectives in medicine.

[56]  N. Pochet,et al.  A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses , 2016, Hepatology.

[57]  B. McMahon,et al.  Present and future therapies of hepatitis B: From discovery to cure , 2015, Hepatology.

[58]  Qiang Deng,et al.  HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase. , 2015, Journal of hepatology.

[59]  Meghan M. Holdorf,et al.  Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation , 2015, Proceedings of the National Academy of Sciences.

[60]  Haitao Guo,et al.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. , 2015, Antiviral research.

[61]  Jianming Hu,et al.  Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation , 2015, Journal of Virology.

[62]  K. Caldecott,et al.  Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair? , 2015, PloS one.

[63]  M. Nassal.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B , 2015, Gut.

[64]  David A. Scott,et al.  CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus , 2015, Scientific Reports.

[65]  A. Bertoletti,et al.  Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. , 2015, Journal of hepatology.

[66]  Zhenghong Yuan,et al.  Regulation of Multiple Stages of Hepadnavirus Replication by the Carboxyl-Terminal Domain of Viral Core Protein in trans , 2014, Journal of Virology.

[67]  C. Seeger,et al.  Targeting Hepatitis B Virus With CRISPR/Cas9 , 2014, Molecular therapy. Nucleic acids.

[68]  Ying Zhu,et al.  MicroRNA-26b Inhibits Hepatitis B Virus Transcription and Replication by Targeting the Host Factor CHORDC1 Protein* , 2014, The Journal of Biological Chemistry.

[69]  I. Ng,et al.  Requirement of CRTC1 coactivator for hepatitis B virus transcription , 2014, Nucleic acids research.

[70]  M. Nassal,et al.  Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses , 2014, Proceedings of the National Academy of Sciences.

[71]  M. Imamura,et al.  Human microRNA hsa‐miR‐1231 suppresses hepatitis B virus replication by targeting core mRNA , 2014, Journal of viral hepatitis.

[72]  Juan Chen,et al.  miR-125b inhibits hepatitis B virus expression in vitro through targeting of the SCNN1A gene , 2014, Archives of Virology.

[73]  E. Sagnelli,et al.  Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection. , 2014, Biochemical and biophysical research communications.

[74]  J. Schiffer,et al.  AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication , 2014, PloS one.

[75]  Shibo Jiang,et al.  Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α , 2014, Nucleic acids research.

[76]  T. Liang,et al.  Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA , 2014, Science.

[77]  A. Lohse,et al.  Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. , 2014, Journal of hepatology.

[78]  Zhenghong Yuan,et al.  An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[79]  Jianming Hu,et al.  Maturation-Associated Destabilization of Hepatitis B Virus Nucleocapsid , 2013, Journal of Virology.

[80]  M. Aichler,et al.  T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. , 2013, Gastroenterology.

[81]  T. Cathomen,et al.  Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[82]  Xiang-Dong Fu,et al.  Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes* , 2013, The Journal of Biological Chemistry.

[83]  Alina Macovei,et al.  Regulation of Hepatitis B Virus Infection by Rab5, Rab7, and the Endolysosomal Compartment , 2013, Journal of Virology.

[84]  M. Buendia,et al.  Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription , 2013, Journal of Virology.

[85]  D. Fan,et al.  MicroRNA-501 promotes HBV replication by targeting HBXIP. , 2013, Biochemical and biophysical research communications.

[86]  K. Morris,et al.  Snapshots: chromatin control of viral infection. , 2013, Virology.

[87]  H. Blum,et al.  T-cell responses in hepatitis B and C virus infection: similarities and differences , 2013, Emerging Microbes & Infections.

[88]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[89]  G. Superti-Furga,et al.  SAMHD1 is a nucleic‐acid binding protein that is mislocalized due to aicardi–goutières syndrome‐associated mutations , 2012, Human mutation.

[90]  A. Cuconati,et al.  Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation , 2012, Antimicrobial Agents and Chemotherapy.

[91]  Angela M. Liu,et al.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.

[92]  Y. Li,et al.  MicroRNA-141 Represses HBV Replication by Targeting PPARA , 2012, PloS one.

[93]  X. Ye,et al.  Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1‐modulated P53 activity , 2012, Hepatology.

[94]  Jianming Hu,et al.  In Vitro Epsilon RNA-Dependent Protein Priming Activity of Human Hepatitis B Virus Polymerase , 2012, Journal of Virology.

[95]  M. Levrero,et al.  IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. , 2012, The Journal of clinical investigation.

[96]  Paul J Rider,et al.  A liver‐specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  Fabien Zoulim,et al.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. , 2011, Journal of hepatology.

[98]  D. Loeb,et al.  Roles of the Envelope Proteins in the Amplification of Covalently Closed Circular DNA and Completion of Synthesis of the Plus-Strand DNA in Hepatitis B Virus , 2011, Journal of Virology.

[99]  Liang Zhang,et al.  MicroRNAs‐372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B , 2011, Hepatology.

[100]  Ju Zhang,et al.  HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state , 2011, Epigenetics.

[101]  Zhiyong Ma,et al.  Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA‐1 , 2011, Hepatology.

[102]  Francesca Zerbini,et al.  Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen , 2011, Nucleic acids research.

[103]  Xin Li,et al.  Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. , 2010, Antiviral research.

[104]  E. Fuchs,et al.  In vivo proliferation of hepadnavirus‐infected hepatocytes induces loss of covalently closed circular DNA in mice , 2010, Hepatology.

[105]  Anton P. McCaffrey,et al.  Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[106]  T. Patel,et al.  MicroRNA‐dependent regulation of DNA methyltransferase‐1 and tumor suppressor gene expression by interleukin‐6 in human malignant cholangiocytes , 2010, Hepatology.

[107]  M. Torbenson,et al.  Hepatitis B Virus Replication Induces Methylation of both Host and Viral DNA , 2010, Journal of Virology.

[108]  M. Levrero,et al.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function , 2009, Proceedings of the National Academy of Sciences.

[109]  T. Block,et al.  Production and Function of the Cytoplasmic Deproteinized Relaxed Circular DNA of Hepadnaviruses , 2009, Journal of Virology.

[110]  Shuhan Sun,et al.  Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.

[111]  Ding‐Shinn Chen,et al.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. , 2009, Gastroenterology.

[112]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans , 2007 .

[113]  A. Cuconati,et al.  Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation , 2007, Journal of Virology.

[114]  Jianming Hu,et al.  Formation of Hepatitis B Virus Covalently Closed Circular DNA: Removal of Genome-Linked Protein , 2007, Journal of Virology.

[115]  M. Kann,et al.  Lipid-Mediated Introduction of Hepatitis B Virus Capsids into Nonsusceptible Cells Allows Highly Efficient Replication and Facilitates the Study of Early Infection Events , 2006, Journal of Virology.

[116]  M. Levrero,et al.  Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. , 2006, Gastroenterology.

[117]  G. Doitsh,et al.  Enhancer I Predominance in Hepatitis B Virus Gene Expression , 2004, Molecular and Cellular Biology.

[118]  S. Litwin,et al.  Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[119]  K. Walters,et al.  Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication , 2002, Journal of Virology.

[120]  M. Manns,et al.  Structural organization of the hepatitis B virus minichromosome. , 2001, Journal of molecular biology.

[121]  M. Yaniv,et al.  Nuclear Covalently Closed Circular Viral Genomic DNA in the Liver of Hepatocyte Nuclear Factor 1α-Null Hepatitis B Virus Transgenic Mice , 2001, Journal of Virology.

[122]  H. Tang,et al.  Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[123]  K. Koike,et al.  The Binding Site of Transcription Factor YY1 Is Required for Intramolecular Recombination between Terminally Repeated Sequences of Linear Replicative Hepatitis B Virus DNA , 2000, Journal of Virology.

[124]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[125]  H. Rho,et al.  Insulin activates the hepatitis B virus X gene through the activating protein-1 binding site in HepG2 cells. , 1998, DNA and cell biology.

[126]  J. Mertz,et al.  Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily , 1997, Journal of virology.

[127]  A. Raney,et al.  Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3 , 1995, Journal of virology.

[128]  A. Ori,et al.  Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3. , 1995, Virology.

[129]  M. Chen,et al.  Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3. , 1994, Virology.

[130]  H. Zentgraf,et al.  Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell , 1994, Virus Genes.

[131]  M. Chen,et al.  Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation , 1993, Molecular and cellular biology.

[132]  A. Raney,et al.  Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor , 1992, Journal of virology.

[133]  A. Siddiqui,et al.  Functional analysis of a liver-specific enhancer of the hepatitis B virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[134]  A. Siddiqui,et al.  Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[135]  A. Horwich,et al.  Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification , 1990, Journal of virology.

[136]  G. Crabtree,et al.  Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[137]  W. Rutter,et al.  Transcription of hepatitis B virus by RNA polymerase II , 1983, Molecular and cellular biology.

[138]  T. Liang,et al.  Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection. , 2019, Gastroenterology.

[139]  W. Delaney,et al.  In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus , 2017 .

[140]  T. Appleby,et al.  Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model , 2017 .

[141]  M. Heikenwalder,et al.  Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. , 2016, Gastroenterology.

[142]  F. Zoulim,et al.  Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.

[143]  S. Urban,et al.  T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. , 2008, Gastroenterology.

[144]  D. Spandau,et al.  Repression of the hepatitis B virus enhancer by a cellular factor. , 1992, The Journal of general virology.